Lithium and the Woozle effect

Bipolar Disorders

Volumn 21, Issue 4, 2019, Pages 302-308

  Kelly, Tammas ^a,b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b The Depression and Bipolar Clinic of Colorado   (United States)

Author keywords

errors; evidence based medicine; journals; lithium; research methods; treatment guidelines

Indexed keywords

LITHIUM; PSYCHOTROPIC AGENT;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; DRUG EFFECT; ERROR; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL SOCIETY; PEER REVIEW; PLACEBO EFFECT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHIATRY; REVIEW; SCIENTIFIC LITERATURE; WOOZLE EFFECT; PATIENT SELECTION;

BIPOLAR DISORDER; EVIDENCE-BASED MEDICINE; HUMANS; LITHIUM; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PSYCHOTROPIC DRUGS;

EID: 85062370843     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12753     Document Type: Review

References (42)

1. Milne AA. Winnie The Pooh. London: Methuen & Co Ltd; 1926.
2. DeJongh B. Lithium use in bipolar disorder: Summary of evidence for acute mania, acute depression, and maintenance treatment. Mental Health Clinician. 2012;2(1):10-14.
3. Cade, JF. Lithium salts in the treatment of psychotic excitement. Medical Journal of Australia. 1949;2(10):349–352.
4. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty J. The expert consensus guideline series: medication treatment of bipolar disorder. Postgrad Med. 2000;1:1-104.
5. Avasthi A, Kumar S, VikasA. Clinical practice guidelines for the management of bipolar affective (mood) disorders. Indian J Psychiatry. 2004;59:S51-S66.
6. Hirschfeld R, American Psychiatric Association. Guideline watch: Practice guideline for the treatment of patients with bipolar disorder. Arlington, VA: American Psychiatric Association; 2005.
7. Management of Bipolar Disorder Working Group Washington: Clinical practice guideline for management of bipolar disorder in adults. Department of Veterans Affairs DoD. VA/DoD 2010.
8. Mok YM, Chan HN, Chee KS, et al. Ministry of Health clinical practice guidelines: bipolar disorder. Singapore Med J. 2011;52:12.
9. Kanba S, Kato T, Terao T, Yamada K; Committee for Treatment Guidelines of Mood Disorders, Japanese Society of Mood Disorders, 2012. Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012. Psychiatry Clin Neurosci. 2013;67(5):285-300.
10. Malhi GS, Bassett D, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2015;49(12):1087-1206.
11. Shah N, Grover S, Rao GP. Clinical practice guidelines for management of bipolar disorder. Indian J Psychiatry. 2017;59(Suppl 1):S51.
12. Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97-170.
13. Woo YS, Bahk W-M, Lee JG, et al. Korean medication algorithm project for bipolar disorder 2018 (KMAP-BP 2018): fourth revision. Clin Psychopharmacol Neurosci. 2018;16(4):434.
14. Bai Y-M, Chang C-J, Tsai S-Y, et al. Taiwan consensus of pharmacological treatment for bipolar disorder. J Chin Med Assoc. 2013;76(10):547-556.
15. Crismon ML, Argo TR, Bendele B, Suppes T. Texas medication algorithm project procedural manual. Bipolar Disorder Algorithms, Texas Department of State Health Services; 2007.
16. Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry. 2010;11(2):81-109.
17. Goodwin G, Haddad P, Ferrier I, et al. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2016;30(6):495-553.
18. Fountoulakis KN, Grunze H, Vieta E, et al. The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: the clinical guidelines. Int J Neuropsychopharmacol. 2017;20(2):180-195.
19. National Collaborating Centre for Mental Health(UK). Bipolar Disorder: The NICE Guideline on the Assessment and Management of Bipolar Disorder in Adults, Children and Young People in Primary and Secondary Care. British Psychological Society; 2018.
20. Selle V, Schalkwijk S, Vázquez G, Baldessarini R. Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics. Pharmacopsychiatry. 2014;47(02):43-52.
21. Zornberg GL, Pope HG. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol. 1993;13(6):397-408.
22. Srisurapanont M, Yatham LN, Zis AP. Treatment of acute bipolar depression: a review of the literature. Can J Psychiat. 1995;40(9):533-544.
23. Greenspan K, Schildkraut JJ, Gordon EK, Baer L, Aronoff MS, Durell J. Catecholamine metabolism in affective disorders—III: MHPG and other catecholamine metabolites in patients treated with lithium carbonate. J Psychiatr Res. 1970;7(3):171-183.
24. Guidance for Industry. E 10 choice of control group and related issues in clinical trials. Federal Drug Administration US Department of Health Human Services. 2001.
25. Stokes PE, Shamoian CA, Stoll PM, Patton MJ. Efficacy of lithium as acute treatment of manic-depressive illness. The Lancet. 1971;297(7713):1319-1325.
26. Fieve Rr, Platman Sr, Plutchik Rh. The use of lithium in affective disorders: I. Acute endogenous depression. Am J Psychiatry. 1968;125(4):487-491.
27. Goodwin FK, Murphy DL, BunneyWE. Lithium-carbonate treatment in depression and mania: a longitudinal double-blind study. Arch Gen Psychiatry. 1969;21(4):486-496.
28. Goodwin FK, Murphy DL, Dunner DL, Bunney WE. Lithium response in unipolar versus bipolar depression. Am J Psychiatry. 1972;129(1):44-47.
29. Noyes R Jr, Dempsey GM, Blum A, Cavanaugh G. Lithium treatment of depression. Compr Psychiatry. 1974;15(3):187-193.
30. Baron M, Gershon ES, Rudy V, Jonas WZ, Buchsbaum MJAogp. Lithium carbonate response in depression: prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Arch Gen Psychiatry. 1975;32(9):1107-1111.
31. Mendels JJ. Lithium in the treatment of depression. Am J Psychiatry. 1976;133(4):373-378.
32. Donnelly EF, Goodwin FK, Waldman IN, MurphyDL. Prediction of antidepressant responses to lithium. Am J Psychiatry. 1978;135(5):552-556.
33. Malhi Gs, Adams D, Lampe L, et al. Clinical practice recommendations for bipolar disorder. Acta Psychiatr Scand. 2009;119:27-46.
34. Carney S, Goodwin G. Lithium–a continuing story in the treatment of bipolar disorder. Acta Psychiatr Scand. 2005;111:7-12.
35. Bhagwagar Z, Goodwin G. The role of lithium in the treatment of bipolar depression. Clin Neurosci Res. 2002;2(3–4):222-227.
36. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007;356(17):1711-1722.
37. Altshuler LL, Sugar CA, McElroy SL, et al. Switch rates during acute treatment for bipolar II depression with lithium, sertraline, or the two combined: a randomized double-blind comparison. Am J Psychiatry. 2017;174(3):266-276.
38. Suppes T, Marangell LB, Bernstein IH, et al. A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. J Affect Disord. 2008;111(2–3):334-343.
39. Young AH, McElroy SL, Bauer M, et al. 001) Investigators. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry. 2010;71(2):150-162.
40. Amsterdam JD, Lorenzo-Luaces L, Soeller I, Li SQ, Mao JJ, DeRubeis RJ. Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate. Br J Psychiatry. 2016;208(4):359-365.
41. KellyTJ. Prospective: is bipolar disorder being overdiagnosed? Int J Methods Psychiatr Res. 2018;27(3):e1725.
42. Kelly T, Denmark L, Lieberman DZ. Elevated levels of circulating thyroid hormone do not cause the medical sequelae of hyperthyroidism. Prog Neuropsychopharmacol Biol Psychiatry. 2016;71:1-6.